Provided by Tiger Fintech (Singapore) Pte. Ltd.

Theravance Biopharma

9.33
+0.20002.19%
Volume:110.09K
Turnover:1.02M
Market Cap:461.84M
PE:-8.08
High:9.36
Open:9.19
Low:9.12
Close:9.13
Loading ...

Company Profile

Company Name:
Theravance Biopharma
Exchange:
NASDAQ
Establishment Date:
2013
Employees:
97
Office Location:
901 Gateway Boulevard,South San Francisco,California,United States
Zip Code:
94080
Fax:
- -
Introduction:
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States and Europe. It offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD). The company's product includes Ampreloxetine, an investigational norepinephrine reuptake inhibitor that has completed Phase III study for neurogenic orthostatic hypotension; and TRELEGY for the treatment of COPD and asthma. It has licensing and collaboration agreements with Pfizer Inc. for its preclinical skin-selective pan-JAK inhibitor program, as well as Viatris Inc. Theravance Biopharma, Inc. was incorporated in 2013 and is based in South San Francisco, California.

Directors

Name
Position
Rick E Winningham
Chief Executive Officer and Chairman of the Board
Burton G. Malkiel
Director
Dean J. Mitchell
Director
Deepika R. Pakianathan
Director
Donal O'Connor
Director
Eran Broshy
Director
George M. Whitesides
Director
Laurie Smaldone Alsup
Director
Robert V. Gunderson, Jr.
Director
Susan M. Molineaux
Director
William D. Young
Director

Shareholders

Name
Position
Rick E Winningham
Chief Executive Officer and Chairman of the Board
Andrew A. Hindman
Senior Vice President and Chief Financial Officer
Brett K. Haumann
Senior Vice President, Chief Medical Officer
Frank Pasqualone
Senior Vice President and Chief Commercial Operations Officer
Kenneth R. Pitzer
Senior Vice President, Product Strategy and Commercial Planning
Philip D. Worboys
Senior Vice President, Research and Translational Science
Richard A. Graham
Senior Vice President, Development
Vijay Sabesan
Senior Vice President, Technical Operations
Ann B. Brady
President
Bradford J. Shafer
Executive Vice President, General Counsel and Secretary